Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gantt P Galloway

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Substance Abuse : Research and Treatment|November 10, 2009
How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine useGantt P Galloway, Edward G Singleton,
Journal of Psychoactive Drugs|May 8, 2015
Text messaging for addiction: a reviewVictoria Keoleian, Douglas Polcin, Gantt P Galloway
Substance Abuse : Research and Treatment|September 28, 2011
Feasibility of Ecological Momentary Assessment Using Cellular Telephones in Methamphetamine Dependent SubjectsGantt P Galloway, Ryne Didier, Kathleen Garrison, et al.
Substance Use & Misuse|February 10, 2006
Measuring confrontation during recovery from addictionDouglas L Polcin, Gantt P Galloway, Thomas K Greenfield
Substance Use & Misuse|April 6, 2004
The case for high-dose motivational enhancement therapyDouglas L Polcin, Gantt P Galloway, James Palmer, et al.
Substance Abuse|April 22, 2010
Development of an acceptance-based coping intervention for alcohol dependence relapse preventionCassandra Vieten, John A Astin, Raymond Buscemi, et al.
BMC Psychiatry|April 5, 2005
Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trialGantt P Galloway, Monika Koch, Ryan Cello, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineJohn Mendelson, Keith Flower, Mark J Pletcher, et al.
Nitric Oxide : Biology and Chemistry|July 13, 2007
Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?Anousheh Kielstein, Dimitrios Tsikas, Gantt P Galloway, et al.
Addictive Behaviors|February 3, 2007
Factor analysis of the Alcohol and Drug Confrontation Scale (ADCS)Douglas L Polcin, Gantt P Galloway, Alan Bostrom, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Substance Abuse : Research and Treatment|November 10, 2009
How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine useGantt P Galloway, Edward G Singleton,
Journal of Psychoactive Drugs|May 8, 2015
Text messaging for addiction: a reviewVictoria Keoleian, Douglas Polcin, Gantt P Galloway
Substance Abuse : Research and Treatment|September 28, 2011
Feasibility of Ecological Momentary Assessment Using Cellular Telephones in Methamphetamine Dependent SubjectsGantt P Galloway, Ryne Didier, Kathleen Garrison, et al.
Substance Use & Misuse|February 10, 2006
Measuring confrontation during recovery from addictionDouglas L Polcin, Gantt P Galloway, Thomas K Greenfield
Substance Use & Misuse|April 6, 2004
The case for high-dose motivational enhancement therapyDouglas L Polcin, Gantt P Galloway, James Palmer, et al.
Substance Abuse|April 22, 2010
Development of an acceptance-based coping intervention for alcohol dependence relapse preventionCassandra Vieten, John A Astin, Raymond Buscemi, et al.
BMC Psychiatry|April 5, 2005
Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trialGantt P Galloway, Monika Koch, Ryan Cello, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineJohn Mendelson, Keith Flower, Mark J Pletcher, et al.
Nitric Oxide : Biology and Chemistry|July 13, 2007
Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?Anousheh Kielstein, Dimitrios Tsikas, Gantt P Galloway, et al.
Addictive Behaviors|February 3, 2007
Factor analysis of the Alcohol and Drug Confrontation Scale (ADCS)Douglas L Polcin, Gantt P Galloway, Alan Bostrom, et al.
Pageof 5